Synaptrabio
SynaptraBIO develops novel therapeutic approaches targeting neurodegenerative brain diseases. Their platform aims to convert currently incurable conditions into treatable or curable states. The company focuses on translating cutting‑edge neuroscience into clinical candidates for patients with severe neurological disorders.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- SynaptraBIO develops novel therapeutic approaches targeting neurodegenerative brain diseases. Their platform aims to convert currently incurable conditions into treatable or curable states. The company focuses on translating cutting‑edge neuroscience into clinical candidates for patients with severe neurological disorders.